أثر سقوط براءات الاختراع للأدوية الأصلية على توجهات السوق العالمي للدواء

Abstract

This study aims to highlight the impact of the fall of patent for the original drug on the global market trends for the drug in a competitive environment characterized by globalization and open markets. This is done to identify the patents in the pharmaceutical industry within the intellectual property agreement, in addition to stand on global trends for the pharmaceutical market and the impact of the loss of patents for many of the original medicines.

The findings from the study to the existence of the impact of the fall of patent for the original drug on the global market trends for the drug. And by slowing down the growth of the latter as a result of patent expirations for some important molecules of medicines, estimated at $ 125 billion during the years 2010-2015. But will this development through the reduction in the share of indigenous medicines compared to an increase in generic drugs. And this led to the rise of emerging countries in the generic medicine industry because of the expiry of the period of protection of intellectual property to the original drugs. By doing so, become pharmerging markets geographical segment the second largest in the pharmaceutical sales in the world, transitive powerful European states and convergence America, which led to the reclassification of the global pharmaceutical organizations and most therapeutic Items sold on the world market.